Cover Image

Nucleoside reverse transcriptase inhibition enhances platelet production and megakaryocyte maturation in patients with COVID‐19

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yubin Li, Juan Wang, Bingqian Huang, Ruixue Wang, Yitong Xu, Ping Zhang, Ruting Wang, Wanru Wang, Junying Cao, Ming Hou, Yu Hou
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	British Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A multicentre randomized open‐label phase 2 trial of dexamethasone plus glycyrrhizinate versus dexamethasone in newly diagnosed immune thrombocytopenia
by: Haoyi Wang, et al.
Published: (2026)

Deregulated megakaryocytic maturation, mitochondrial function and inflammatory signalling in CYCS (c.292T>C) ‐related thrombocytopenia
by: Konstantina Giavi, et al.
Published: (2026)

CDK8 /19 inhibition triggers a switch from mitosis to endomitosis in cord blood megakaryocytes
by: Zhi‐Jian Liu, et al.
Published: (2024)

Effects of orelabrutinib, a BTK inhibitor, on antibody‐mediated platelet destruction in primary immune thrombocytopenia
by: Tian‐shu Yu, et al.
Published: (2025)

MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia
by: Zhenyu Liu, et al.
Published: (2026)

Monolobated megakaryocytes and ring sideroblasts: A morphological prelude to multihit TP53 and complex karyotype
by: Javier Marco‐Ayala, et al.
Published: (2025)

‘Pseudothrombocytopenia’ a contradictory term in patients with normal platelet counts?
by: Peter Schuff‐Werner
Published: (2025)

Neutrophil extracellular traps induced by activated platelets as a cause of neutrophil–platelet aggregation in β‐thalassaemia/haemoglobin E patients
by: Rattanawan Thubthed, et al.
Published: (2026)

Interplay of leucocyte–platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients
by: Rubén Osuna‐Gómez, et al.
Published: (2024)

Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series
by: Ekaterina Balaian, et al.
Published: (2026)

Course of immune thrombocytopenia according to the site of platelet destruction identified by indium‐111 platelet scintigraphy
by: Pauline Durand, et al.
Published: (2024)

The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets
by: Morten Orebo Holmström, et al.
Published: (2024)

COVID‐19 vaccination in splenectomized patients with immune thrombocytopenia—Response
by: Xiang Liu, et al.
Published: (2024)

Anti‐platelet factor 4 immunothrombotic syndromes
by: Richard J. Buka, et al.
Published: (2024)

The importance of ABO in platelet refractoriness, an often overlooked option
by: Richard Gammon, et al.
Published: (2024)

Anti‐ CD38 therapy in immune thrombocytopenia ( ITP )
by: Waleed Ghanima, et al.
Published: (2026)

Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk
by: Ana Marín‐Quílez, et al.
Published: (2025)

The usefulness of indium‐111 platelet scintigraphy beyond predicting efficacy of splenectomy
by: Nora Butta, et al.
Published: (2024)

Apoptosis and platelet biogenesis: A new piece of information on a debated topic
by: Carlo Zaninetti, et al.
Published: (2024)

Clonal haematopoiesis associates with distinct cytometric changes of red blood cells and platelets
by: J. B. Salzbrunn, et al.
Published: (2025)

Determinants of the haemoglobin level in patients with sickle cell disease living in sub‐Saharan Africa: Major impact of the country of residence and independent effects of leucocyte and platelet counts and haemolysis
by: Marica Rossi, et al.
Published: (2024)

Comparative study of the diversity of amino acids on human leucocyte antigen class II molecules in patients with acquired aplastic anaemia
by: Jun Qi, et al.
Published: (2024)

Ten years of RASGRP2 ‐related platelet disorder: Implications for molecular haematology and diagnostics
by: Jehan Mousa, et al.
Published: (2025)

Service evaluation of R90 bleeding and platelet disorders gene panel in thrombocytopenia cases
by: G. Gurumurthy, et al.
Published: (2024)

Opportunities for improving platelet transfusion practice: A large retrospective audit across 22 hospitals
by: Sarah Ryan, et al.
Published: (2025)

Update on B‐cell maturation antigen‐directed therapies in AL amyloidosis
by: Krzysztof Jamroziak, et al.
Published: (2025)

Anti‐ HPA ‐1a IgG3 subclass antibodies induce strong platelet phagocytosis
by: Silke Schmidt, et al.
Published: (2026)

An open‐label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome
by: Haiyan He, et al.
Published: (2024)

COVID‐19 vaccination in splenectomized patients with immune thrombocytopenia: Correspondence
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia
by: Peiqi Liang, et al.
Published: (2024)

BCL2 inhibition for multiple myeloma and AL amyloidosis
by: Lorenzo Cani, et al.
Published: (2025)

Clinical and molecular characteristics of paediatric mature B‐cell acute lymphocytic leukaemia and non‐Hodgkin lymphoma with bone marrow involvement: A joint study between the CCCG leukaemia and lymphoma groups
by: Jie Zhao, et al.
Published: (2025)

CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma
by: Emil Arjun Kumar, et al.
Published: (2024)

Machine learning based on multiplatform tests assists in subtype classification of mature B‐cell neoplasms
by: Junwei Lin, et al.
Published: (2024)

Co‐inheritance of ITGA2B and TUBB1 variants in a family reveals distinct genetic contributions to platelet dysfunction
by: Perla Bandini, et al.
Published: (2026)

Anti‐ HSP90α IgG may protect against antiphospholipid syndrome in systemic lupus erythematosus by reducing platelet activation
by: Marina Barguil Macêdo, et al.
Published: (2025)

Up‐front autologous stem cell transplant in peripheral T‐cell lymphoma patients achieving complete response after first‐line treatment: A multicentre real‐world analysis
by: Peipei Yang, et al.
Published: (2024)

Forecasting optimal treatments in relapsed/refractory mature T‐ and NK‐cell lymphomas: A global PETAL Consortium study
by: Mark N. Sorial, et al.
Published: (2025)

EASIX score predicts non‐relapse mortality and severe infection in elderly patients undergoing allo‐HSCT
by: Lizhen Liu, et al.
Published: (2025)

Time‐dependent in vitro variations of platelet count in samples from subjects with EDTA‐induced pseudothrombocytopenia: A comparative analysis across different anticoagulants
by: Claudia Ghali, et al.
Published: (2024)